Skip to main content
Top
Published in: BMC Gastroenterology 1/2015

Open Access 01-12-2015 | Research article

The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancer

Authors: Ying Chen, Renquan Lu, Hui Zheng, Ran Xiao, Jingjing Feng, Hongling Wang, Xiang Gao, Lin Guo

Published in: BMC Gastroenterology | Issue 1/2015

Login to get access

Abstract

Background

We have demonstrated previously that NFKB1 single nucleotide polymorphism (SNP) rs4648068 GG homozygote was associated with the increased risk of gastric cancer in Chinese Han population. In this study, we constructed the recombinant plasmid pGL3-AA, pGL3-GG, pGL3-AA-NFKB and pGL3-GG-NFKB to investigate the function of rs4648068 by cell biology experiments.

Methods

Quantitative real-time PCR was used to detect NFKB1 SNP rs4648068 genotype in the patients with gastric cancer. Anti-NF-κB1 p50 polyclonal antibodies were used for immunohistochemical analysis of the tissue specimens. The subsection of NFKB1 containing the promoter site and adjacent three consecutive exons were obtained by PCR technique and subcloned into the vector pGL3-Basic. Dual-Luciferase reporter assay was used to detect the transcriptional activity of the constructed promoter. Effects of transcription factor NFKB1 on C/EBPβ expression were determined by chromatin immunoprecipitation and Western analysis. Furthermore, proliferation and invasion ability of the transduced cell were also measured and compared.

Results

Intensive staining for p50 expression was observed in the tissues of GG genotype patients, compared with those of GA group and AA genotype patients. The transcriptional activity of rs4648068 (A > G) by dual-Luciferase reporter assay suggested that the luciferase activity of homozygote group (pGL3-GG) was greater than that of the control (pGL3-AA), especially at the stimulation of LPS. We found that the luciferase activity was also influenced by pGL3-GG levels. The effects of NFKB1 rs4648068 were enhanced by rs4648065 on the transduced cells. The interaction between NFKB1 promoter nucleotide sequence and C/EBPβ was regulated by the functional SNP rs4648068 in SGC-7901 cells. Our data indicated that the transduction of pGL3 expression plasmid pGL3-GG-NFKB improved the proliferation and motility of gastric cancer cells. Correspondingly, the homozygote GG of SNP rs4648068 strengthened the transcriptional activity of NFKB1 and influenced the cell biological activity.

Conclusion

The transcriptional activity of NFKB1 was associated with SNP rs4648068, and this functional SNP site has the important effects on cell proliferation and motility.
Literature
1.
go back to reference Chen CD, Sawyers CL. NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol. 2002;22(8):2862–70.CrossRefPubMedPubMedCentral Chen CD, Sawyers CL. NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol. 2002;22(8):2862–70.CrossRefPubMedPubMedCentral
2.
go back to reference Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301–10.CrossRefPubMed Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2(4):301–10.CrossRefPubMed
3.
go back to reference Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Ann Rev Cell Biol. 1994;10:405–55.CrossRefPubMed Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Ann Rev Cell Biol. 1994;10:405–55.CrossRefPubMed
4.
go back to reference Baldwin Jr AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann Rev Immunol. 1996;14:649–83.CrossRef Baldwin Jr AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann Rev Immunol. 1996;14:649–83.CrossRef
5.
go back to reference Wang W, Abbruzzese JL, Evans DB, Chiao PJ. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene. 1999;18(32):4554–63.CrossRefPubMed Wang W, Abbruzzese JL, Evans DB, Chiao PJ. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene. 1999;18(32):4554–63.CrossRefPubMed
6.
go back to reference Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer. 2000;89(11):2274–81.CrossRefPubMed Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer. 2000;89(11):2274–81.CrossRefPubMed
7.
go back to reference Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci U S A. 2001;98(18):10386–91.CrossRefPubMedPubMedCentral Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci U S A. 2001;98(18):10386–91.CrossRefPubMedPubMedCentral
8.
go back to reference Pan X, Li Y, Feng J, Wang X, Hao B, Shi R, et al. A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients. BMC Cancer. 2013;13:126.CrossRefPubMedPubMedCentral Pan X, Li Y, Feng J, Wang X, Hao B, Shi R, et al. A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients. BMC Cancer. 2013;13:126.CrossRefPubMedPubMedCentral
9.
go back to reference Xu M, Tao G, Kang M, Gao Y, Zhu H, Gong W, et al. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population. PLoS One. 2013;8(3):e60080.CrossRefPubMedPubMedCentral Xu M, Tao G, Kang M, Gao Y, Zhu H, Gong W, et al. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population. PLoS One. 2013;8(3):e60080.CrossRefPubMedPubMedCentral
10.
go back to reference Lu R, Gao X, Chen Y, Ni J, Yu Y, Li S, et al. Association of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population. BMC Gastroenterol. 2012;12:87.CrossRefPubMedPubMedCentral Lu R, Gao X, Chen Y, Ni J, Yu Y, Li S, et al. Association of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population. BMC Gastroenterol. 2012;12:87.CrossRefPubMedPubMedCentral
11.
go back to reference Lu R, Wu C, Guo L, Liu Y, Mo W, Wang H, et al. The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo. BMC Cancer. 2012;12:607.CrossRefPubMedPubMedCentral Lu R, Wu C, Guo L, Liu Y, Mo W, Wang H, et al. The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo. BMC Cancer. 2012;12:607.CrossRefPubMedPubMedCentral
12.
go back to reference Long YM, Ye S, Rong J, Xie WR. Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinoma. World J Gastroenterol. 2008;14(30):4739–44.CrossRefPubMedPubMedCentral Long YM, Ye S, Rong J, Xie WR. Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinoma. World J Gastroenterol. 2008;14(30):4739–44.CrossRefPubMedPubMedCentral
13.
go back to reference Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Jang JS, et al. Clinicopathologic significance of expression of nuclear factor-kappaB RelA and its target gene products in gastric cancer patients. World J Gastroenterol. 2012;18(34):4744–50.CrossRefPubMedPubMedCentral Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Jang JS, et al. Clinicopathologic significance of expression of nuclear factor-kappaB RelA and its target gene products in gastric cancer patients. World J Gastroenterol. 2012;18(34):4744–50.CrossRefPubMedPubMedCentral
14.
go back to reference Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res. 2001;7(12):4136–42.PubMed Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res. 2001;7(12):4136–42.PubMed
15.
go back to reference Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, Morisaki T, et al. Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma. Anticancer Res. 2004;24(2C):1071–5.PubMed Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, Morisaki T, et al. Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma. Anticancer Res. 2004;24(2C):1071–5.PubMed
16.
go back to reference Zhao F, Chen X, Meng T, Hao B, Zhang Z, Zhang G. Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer. BMC Cancer. 2012;12:477.CrossRefPubMedPubMedCentral Zhao F, Chen X, Meng T, Hao B, Zhang Z, Zhang G. Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer. BMC Cancer. 2012;12:477.CrossRefPubMedPubMedCentral
17.
go back to reference Bayerer B, Stamer U, Hoeft A, Stuber F. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene. Eur J Pain. 2007;11(4):421–7.CrossRefPubMed Bayerer B, Stamer U, Hoeft A, Stuber F. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene. Eur J Pain. 2007;11(4):421–7.CrossRefPubMed
18.
go back to reference Verma VK, Taneja V, Jaiswal A, Sharma S, Behera D, Sreenivas V, et al. Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rbeta2 promoter in Indian tuberculosis patients. PLoS One. 2012;7(4):e34355.CrossRefPubMedPubMedCentral Verma VK, Taneja V, Jaiswal A, Sharma S, Behera D, Sreenivas V, et al. Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rbeta2 promoter in Indian tuberculosis patients. PLoS One. 2012;7(4):e34355.CrossRefPubMedPubMedCentral
19.
go back to reference Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999;18(49):6853–66.CrossRefPubMed Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999;18(49):6853–66.CrossRefPubMed
20.
go back to reference Kato T, Kitagawa S. Regulation of neutrophil functions by proinflammatory cytokines. Int J Hematol. 2006;84(3):205–9.CrossRefPubMed Kato T, Kitagawa S. Regulation of neutrophil functions by proinflammatory cytokines. Int J Hematol. 2006;84(3):205–9.CrossRefPubMed
21.
go back to reference Liu JL, Liang Y, Wang ZN, Zhou X, Xing LL. Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysis. World J Gastroenterol. 2010;16(43):5510–7.CrossRefPubMedPubMedCentral Liu JL, Liang Y, Wang ZN, Zhou X, Xing LL. Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysis. World J Gastroenterol. 2010;16(43):5510–7.CrossRefPubMedPubMedCentral
22.
go back to reference Wu DM, Zhu HX, Zhao QH, Zhang ZZ, Wang SZ, Wang ML, et al. Genetic variations in the SMAD4 gene and gastric cancer susceptibility. World J Gastroenterol. 2010;16(44):5635–41.CrossRefPubMedPubMedCentral Wu DM, Zhu HX, Zhao QH, Zhang ZZ, Wang SZ, Wang ML, et al. Genetic variations in the SMAD4 gene and gastric cancer susceptibility. World J Gastroenterol. 2010;16(44):5635–41.CrossRefPubMedPubMedCentral
23.
go back to reference Paz-Priel I, Houng S, Dooher J, Friedman AD. C/EBPalpha and C/EBPalpha oncoproteins regulate nfkb1 and displace histone deacetylases from NF-kappaB p50 homodimers to induce NF-kappaB target genes. Blood. 2011;117(15):4085–94.CrossRefPubMedPubMedCentral Paz-Priel I, Houng S, Dooher J, Friedman AD. C/EBPalpha and C/EBPalpha oncoproteins regulate nfkb1 and displace histone deacetylases from NF-kappaB p50 homodimers to induce NF-kappaB target genes. Blood. 2011;117(15):4085–94.CrossRefPubMedPubMedCentral
24.
go back to reference Schmid RM, Perkins ND, Duckett CS, Andrews PC, Nabel GJ. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature. 1991;352(6337):733–6.CrossRefPubMed Schmid RM, Perkins ND, Duckett CS, Andrews PC, Nabel GJ. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature. 1991;352(6337):733–6.CrossRefPubMed
25.
go back to reference Dooher JE, Paz-Priel I, Houng S, Baldwin Jr AS, Friedman AD. C/EBPalpha, C/EBPalpha oncoproteins, or C/EBPbeta preferentially bind NF-kappaB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction. Mol Cancer Res. 2011;9(10):1395–405.CrossRefPubMedPubMedCentral Dooher JE, Paz-Priel I, Houng S, Baldwin Jr AS, Friedman AD. C/EBPalpha, C/EBPalpha oncoproteins, or C/EBPbeta preferentially bind NF-kappaB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction. Mol Cancer Res. 2011;9(10):1395–405.CrossRefPubMedPubMedCentral
Metadata
Title
The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancer
Authors
Ying Chen
Renquan Lu
Hui Zheng
Ran Xiao
Jingjing Feng
Hongling Wang
Xiang Gao
Lin Guo
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2015
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-015-0243-0

Other articles of this Issue 1/2015

BMC Gastroenterology 1/2015 Go to the issue